Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
11 hours ago
By
Carole Leach-Lemens
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to

Published
11 hours ago
By
Keith Alcorn
International study of gay couples reports no transmissions from an HIV-positive partner on treatment

A study of 343 gay couples, where one partner had HIV and the other did not, has not found a single case of HIV transmission in

Published
14 hours ago
By
Gus Cairns
New integrase inhibitor bictegravir works well for first-line HIV treatment

A single-tablet regimen containing the experimental integrase inhibitor bictegravir was as effective as two widely used approved regimens for first-line therapy in a pair of phase 3 clinical

Published
16 hours ago
By
Liz Highleyman
South African child has controlled HIV off treatment for 8.5 years

A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus

Published
24 July 2017
By
Keith Alcorn
Less frequent clinic visits for HIV care: fine tuning needed

Shifts to less frequent clinic visits and medication pick-ups to free up healthcare resources and make life easier for people living with HIV are being implemented successfully

Published
24 July 2017
By
Keith Alcorn
Swaziland: new infections halved in five years as HIV treatment scales up

New HIV infections have halved in Swaziland since 2011 at the same time as the proportion of people on antiretroviral treatment with fully suppressed viral load has

Published
24 July 2017
By
Keith Alcorn
Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

Two long-acting injectable antiretrovirals, cabotegravir and rilpivirine, administered once every 4 or 8 weeks maintained viral suppression in about 90% of people who started therapy with an undetectable

Published
24 July 2017
By
Liz Highleyman
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.

Published
23 July 2017
From
World Health Organization
HIV and cancer teams double up to seek out new disease killers

HIV experts at an international conference starting on Saturday are keenly courting colleagues in oncology to explore whether advances in harnessing the immune system against cancer can help the search for a cure for AIDS.

Published
22 July 2017
From
Reuters
← First12345...446Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.